Human parvovirus B19 non-structural protein (NS1) induces apoptosis through mitochondria cell death pathway in COS-7 cells

References

• Cossart YE, Field AM, Cant B, Widdows D. Parvovirus-like particles in human sera. Lancet 1975; 1: 72–3.
   PubMed Web of Science ®Google Scholar
• Finkel TH, Torok TJ, Ferguson PJ, Durigon EL, Zaki SR, Leung DY, et al. Chronic parvovirus B19 infection and systemic necrotizing vasculitis: opportunistic infection or etiological agent? Lancet 1994; 343: 1255–8.
   PubMed Web of Science ®Google Scholar
• Nesher G, Osborn TG, Moore TL. Parvovirus infection mimicking systemic lupus erythematosus. Semin Arthritis Rheum 1995; 24: 297–303.
   Google Scholar
• Bultmann BD, Klingel K, Sotlar K, Bock CT, Kandolf R. Parvovirus B19: a pathogen responsible for more than hematologic disorders. Virchows Arch 2003; 442: 8–17.
   Google Scholar
• Chou CTN, Hsu TC, Chen RM, Lin LI, Tsay GJ. Parvovirus B19 infection associated with the production of anti-neutrophil cytoplasmic antibody (ANCA) and anticardiolipin antibody (aCL). Lupus 2000; 9: 551–4.
   Google Scholar
• Von Landenberg P, Lehmann HW, Knoll A, Dorsch S, Modrow S. Antiphospholipid antibodies in pediatric and adult patients with rheumatic disease are associated with parvovirus B19 infection. Arthritis Rheum 2003; 48: 1939–47.
   Google Scholar
• Hsu TC, Tsay GJ. Human parvovirus B19 infection in patients with systemic lupus erythematosus. Rheumatology (Oxford) 2001; 40: 152–7.
   PubMed Web of Science ®Google Scholar
• Kalish RA, Knopf AN, William Gary G, Canoso JJ. Lupus-like presentation of human parvovirus B19 infection. J Rheum 1992; 19: 169–71.
   PubMed Web of Science ®Google Scholar
• Takahashi Y, Murai C, Shibata S, Munakata Y, Ishii T, Ishii K, et al. Human parvovirus B19 as a causative agent for rheumatoid arthritis. Proc Natl Acad Sci USA 1998; 95: 8227–32.
   PubMed Web of Science ®Google Scholar
• Trapani S, Ermini M, Falcini F. Human parvovirus B19 infection: its relationship with systemic lupus erythematosus. Semin Arthritis Rheum 1999; 28: 319–25.
   Google Scholar
• Lehmann HW, von Landenberg P, Modrow S. Parvovirus B19 infection and autoimmune disease. Autoimmun Rev 2003; 2: 218–23.
   PubMed Web of Science ®Google Scholar
• Morita E, Sugamura K. Human parvovirus B19-induced cell cycle arrest and apoptosis. Springer Semin Immunopathol 2002; 24: 187–99.
   PubMed Web of Science ®Google Scholar
• Soderlund-Venermo M, Hokynar K, Nieminen J, Rautakorpi H, Hedman K. Persistence of human parvovirus B19 in human tissues. Pathol Biol (Paris) 2002; 50: 307–16.
   PubMed Web of Science ®Google Scholar
• Hokynar K, Soderlund-Venermo M, Pesonen M, Ranki A, Kiviluoto O, Partio EK, Hedman K. A new parvovirus genotype persistent in human skin. Virology 2002; 302: 224–8.
   PubMed Web of Science ®Google Scholar
• Pattison JR. Human parvoviruses. In: Zuckerman AJ, Banatvala JE, Pattison JR, eds. Principles and practice of clinical virology. New York: John Wiley and Sons, Ltd; 2000. p. 645–58.
   Google Scholar
• Young NS. Parvoviruses. In: Fields BN, Knipe DM, Howley PM, et al, eds. Fields virology. Philadelphia: Lippincott Raven; 1996. p. 2199–236.
   Google Scholar
• Ozawa K, Ayub J, Kajigaya S, Shimada T, Young N. The gene encoding the non-structural protein of B19 (human) parvovirus may be lethal in transfected cells. J Virol 1988; 62: 2884–9.
   Google Scholar
• Raab U, Beckenlehner K, Lowin T, Niller HH, Doyle S, Modrow S. NS1 protein of parvovirus B19 interacts directly with DNA sequences of the p6 promoter and with the cellular transcription factors Sp1/Sp3. Virology 2002; 293: 86–93.
   PubMed Web of Science ®Google Scholar
• Koch WC. Fifth (human parvovirus) and sixth (herpes virus 6) disease. Curr Opin Infect Dis 2001; 14: 343–56.
   PubMed Web of Science ®Google Scholar
• Morita E, Nakashima A, Asao H, Sato H, Sugamura K. Human parvovirus B19 nonstructuralprotein (NS1) induces cell cycle arrest at G(1) phase. J Virol 2003; 77: 2915–21.
   Google Scholar
• Sol N, Le Junter J, Vassias I, Freyssinier JM, Thomas A, Prigent AF, et al. Possible interactions between the NS1 protein and tumor necrosis factor alpha pathways in erythroid cell apoptosis induced by human parvovirus B19. J Virol 1999; 73: 8762–70.
   PubMed Web of Science ®Google Scholar
• Yaegashi N, Niinuma T, Chisaka H, Uehara S, Moffatt S, Tada K, et al. Parvovirus B19 infection induces apoptosis of erythroid cells in vitro and in vivo. J Infect 1999; 39: 68–76.
   PubMed Web of Science ®Google Scholar
• Gartel AL, Tyner AL. The role of the cyclin-dependent kinase inhibitor p21 in apoptosis. Mol Cancer Ther 2002; 1: 639–49.
   PubMed Web of Science ®Google Scholar
• Tzang BS, Chiang YJ, Lan HC, Liao CB, Liu YC. Tuning up or down the UV-induced apoptosis in Chinese hamster ovary cells with cell cycle inhibitors. Photochem Photobiol 2002; 75: 662–7.
   Google Scholar
• Towbin H, Staehelin T, Gordon J. Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc Natl Acad Sci USA 1979; 76: 4350–4.
   Google Scholar
• Komarov PG, Komarova EA, Kondratov RV, Christov-Tselkov K, Coon JS, Chernov MV, Gudkov AV. A chemical inhibitor of p53 that protects mice from the side-effects of cancer therapy. Science 1999; 285: 1733–7.
   Google Scholar
• St Amand J, Astell CR. Identification and characterization of a family of 11-kDa proteins encoded by the human parvovirus B19. Virology 1993; 192: 121–31.
   PubMed Web of Science ®Google Scholar
• Moffatt S, Yaegashi N, Tada K, Tanaka N, Sugamura K. Human parvovirus B19 non-structural (NS1) protein induces apoptosis in erythroid lineage cells. J Virol 1998; 72: 3018–28.
   Google Scholar
• Degli Esposti M, Dive C. Mitochondrial membrane permeabi-lization by Bax/Bak. Biochem Biophys Res Commun 2003; 304: 455–61.
   PubMed Web of Science ®Google Scholar
• Falke D, Fisher M, Ye D, Juliano RL. Design of artificial transcription factors to selectively regulate the pro-apoptotic bax gene. Nucleic Acids Res 2003; 31: e10.
   PubMed Web of Science ®Google Scholar
• Marchenko ND, Zaika A, Moll UM. Death signal-induced localization of p53 protein to mitochondria: a potential role in apoptotic signaling. J Biol Chem 2000; 275: 16202–12.
   Google Scholar
• van Gurp M, Festjens N, van Loo G, Saelens X, Vandenabeele P. Mitochondrial intermembrane proteins in cell death. Biochem Biophys Res Commun 2003; 304: 487–97.
   PubMed Web of Science ®Google Scholar
• Schwarz TF, Wiersbitzky S, Pambor M. Case report: detection of parvovirus B19 in a skin biopsy of a patient with erythema infectiosum. J Med Virol 1994; 43: 171–4.
   Google Scholar
• Takahashi M, Ito M, Sakamoto F, Shimizu N, Furukawa T, Takahashi M, Matsunaga Y. Human parvovirus B19 infection: immunohistochemical and electron microscopic studies of skin lesions. J Cutan Pathol 1995; 22: 168–72.
   Google Scholar
• Cohen BJ, Field AM, Mori J, Brown KE, Clewley JP, St Amand J, Astell CR. Morphology and antigenicity of recombinant B19 parvovirus capsids expressed in transfected COS-7 cells. J Gen Virol 1995; 76: 1233–7.
   Google Scholar
• Chisaka H, Morita E, Murata K, Ishii N, Yaegashi N, Okamura K, Sugamura K. A transgenic mouse model for non-immune hydrops fetalis induced by the NS1 gene of human parvovirus B19. J Gen Virol 2002; 83: 273–81
   Google Scholar